Mitazalimab Antibody
Mitazalimab (ADC-1013) is a CD40-targeting agonistic monoclonal IgG antibody. It activates antigen-presenting cells, induces transient peripheral transcriptomic changes, and demonstrates antitumor activity, making it a valuable tool for immuno-oncology research in both in vitro and in vivo experimental models.
Product Specifications
Product Name Alternative
ADC-1013, AD-1013, CD40, JNJ64457107, JNJ-64457107, JNJ7107, JNJ 7107
Target
TNF
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cell Biology
Concentration
5.93 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
143.42 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog